Biden’s Decision on Apple-Masimo ITC Patent Case Due Dec 25

Summary

  • The Biden Administration is up against a Dec. 25 deadline to decide whether or not to veto a public policy-related ban.
  • Apple has requested a temporary suspension of the order from the ITC while the case is currently being appealed or amidst a potential government shutdown.
  • A patent dispute over technology enabling the blood oxygen feature on certain Apple smartwatches was won by Masimo (NASDAQ:).

The looming Dec. 25 deadline placed upon the Biden Administration is to review a ban for public policy reasons.

In the middle of this situation, Apple is initiating action towards the International Trade Commission (ITC), seeking a temporary halt on the order while the unfolding case awaits an appeal, or in the event of potential governmental shutdown.

In other news, an ITC patent case over a certain technological feature highlighting the blood oxygen aspect on select models of Apple’s smartwatches has been ruled in favor of the medical devices manufacturer, Masimo (NASDAQ:).

These shifting tides in the tech and financial spheres may have significant influences on assets tied to these industries and potential trading opportunities especially within the forex market.

PIP Penguin
Logo